Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Background: Vitamin D (VD) deficiency in chronic lymphocytic leukemia (CLL) is associated with inferior prognosis, shorter time to treatment and worse overall survival. VD deficiency is the first potentially modifiable prognostic factor in CLL. Currently, however, there is a lack of studies concerning VD supplementation in CLL patients.Aim: To evaluate the efficacy and safety of VD supplementation in patients with CLL. Methods: A 6-month interventional study was conducted in CLL patients with lower serum 25-OH-D3 concentrations (< 30 ng/ml) than currently recommended. Patients with VD insufficiency (20-30 ng/ml) received 2000 IU of cholecalciferol/day, patients with moderate deficiency (10-19.9 ng/ml) received 4000 IU/day, and patients with severe VD deficiency (<10 ng/ml) received 6000 IU/day. Results: In the analyzed group of 13 CLL subjects, only 1 patient had a VD level within the optimal range (30-80 ng/ml), 7 had an insufficient concentration, 4 had moderate deficiency, and 1 had severe deficiency. Secondary hyperparathyroidism was diagnosed in 4 subjects. Cholecalciferol supplementation (mean dose of 3384 ± 1211 IU) was followed by a significant increase in 25-OH-D3 concentration (from 17.3 ± 5.8 to 41.4 ± 17.5 ng/ml; p<0.05) and decrease in PTH (p<0.05). Five patients did not achieve the recommended 25-OH-D3 concentration. Calcium level remained unchanged and no patients developed hypercalcemia.Conclusions: VD replenishment is safe and can be effectively achieved by means of the employed cholecalciferol dosage in the majority of patients. However, some subjects may require higher doses to obtain the optimal level and immune function.

Authors and Affiliations

Marcin Kubeczko, Elżbieta Nowara, Wojciech Spychałowicz, Kamil Wdowiak, Anna Bednarek, Dobromiła Karwasiecka, Jerzy Chudek

Keywords

Related Articles

Immunoterapie nowotworów działające na punkty kontrolne układu odpornościowego

Komórki nowotworowe mogą zawierać na powierzchni antygeny, które doprowadzają do wykształcenia się odpowiedzi odpornościowej przeciwko nim. Nowotwór w organizmie ludzkim może wytwarzać wokół siebie immunosupresyjne środo...

Effect of methylprednisolone, hyaluronic acid and pioglitazone on histological remodeling of temporomandibular joint cartilage in rabbits affected by drug-induced osteoarthritis

Background: The aims of this study were to assess the anti-degenerative effects of pioglitazone and to compare these effects with those of methylprednisolone and hyaluronic acid on drug-induced osteoarthritis in rabbits’...

Immunoregulacyjne działanie melatoniny. Mechanizm działania i wpływ na komórki procesu zapalnego

Dane literaturowe wskazują na znaczącą rolę melatoniny w regulowaniu układu immunologicznego. Funkcję tę może pełnić bezpośrednio, oddziałując na komórki układu odpornościowego zawierające receptory dla melatoniny, ale r...

Surface proteins of bacteria of the genus Bifidobacterium

Beneficial effects due to the presence of probiotic bacteria of the genus Bifidobacterium in the human intestinal tract are still an interesting object of study. So far activities have been confirmed of bifidobacteria in...

Download PDF file
  • EP ID EP220688
  • DOI -
  • Views 119
  • Downloads 0

How To Cite

Marcin Kubeczko, Elżbieta Nowara, Wojciech Spychałowicz, Kamil Wdowiak, Anna Bednarek, Dobromiła Karwasiecka, Jerzy Chudek (2016). Efficacy and safety of vitamin D supplementation in patients with chronic lymphocytic leukemia. Advances in Hygiene and Experimental Medicine, 70(), 534-541. https://europub.co.uk/articles/-A-220688